[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369740-105":59,"doc-detail-369740-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","development-of-4t1-breast-cancer-mouse-model-system-for-preclinical-carbonic-anhydrase-ix-studies","Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies","","Triple-negative breast cancer remains an aggressive subtype with limited targeted options. Carbonic anhydrase IX (CAIX) is overexpressed under hypoxia and represents a promising target for therapeutic evaluation. This study builds a robust 4T1-based murine TNBC model by generating two genetically edited cell line variants, enabling negative and positive controls for CAIX production. After orthotopic implantation into syngeneic BALB/c mice, CAIX-deficient tumors showed reduced growth and metastasis, whereas CAIX-expressing tumors displayed vascularized phenotypes with central coagulative necrosis. CAIX expression stability was monitored in vivo using a high-affinity CAIX-specific NIR probe, and constitutive CAIX expression did not trigger autoantibody responses, supporting CAIX vaccination assessment. The study was replicated independently and confirmed model robustness. ",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-4t1-breast-cancer-mouse-model-system-for-preclinical-carbonic-anhydrase-ix-studies/369740/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-4t1-breast-cancer-mouse-model-system-for-preclinical-carbonic-anhydrase-ix-studies/369740.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of developing the 4T1-based CAIX model system?","Question",{"text":113,"@type":114},"The goal is to create a murine TNBC model suitable for comprehensive preclinical evaluation of targeting CAIX, using genetically edited cell line variants to provide clear negative and positive controls.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the CAIX-modulating cell lines generated and used?",{"text":118,"@type":114},"The model is based on the original 4T1 breast cancer line and two edited versions: one with biallelic CRISPR/Cas9-mediated Car9 inactivation and another with constitutive Car9/CAIX expression.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study show after orthotopic implantation in syngeneic BALB/c mice?",{"text":122,"@type":114},"CAIX-deficient tumors exhibited significantly reduced primary tumor growth and metastatic progression, while CAIX-expressing tumors showed vascularized phenotypes with prominent central coagulative necrosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369740,1790243984,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","RESEARCH ARTICLE  \nDevelopment of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies  \nZane Kalni ¸na 1,2 , Ilva Liekni ¸na 1, Svetlana Koteloviˇca 1, Ramona Petrovska 1, Gediminas ˇZvinys3, Agne Petrosiute3, Asta Zubriene˙3 , Matı¯ss Toms Laugalis2, Vendija Skeltona2, Juris Jansons 1 , Madara Kreishmane 1, Edita ˇCapkauskaite˙3, Daumantas Matulis3 and Kaspars Ta¯rs 1,2  \n1 Latvian Biomedical Research and Study Centre, Riga, Latvia  \n2 Faculty of Medicine and Life Sciences, University of Latvia, Riga, Latvia  \n3 Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Lithuania  \nKeywords  \n4T1 model; breast cancer; cancer imaging; carbonic anhydrase IX; hypoxia; preclinical models  \nCorrespondence  \nZ. Kalni¸na, Latvian Biomedical Research and Study centre, Ratsupites 1, k1, LV-1067, Riga, Latvia  \nE-mail: [zane.kalnina@biomed.lu.lv](zane.kalnina@biomed.lu.lv)  \nSvetlana Koteloviˇca and Madara Kreishmane are corporate alumni.  \n(Received 24 January 2025, revised 10 April 2025, accepted 30 April 2025)  \ndoi:10.1002/2211-5463.70052  \nEdited by Ivana Novak  \nTriple-negative breast cancer (TNBC) is the most aggressive type of breast cancer, for which targeted treatment is currently lacking. Carbonic anhydrase IX (CAIX) is a known cancer target due to its selective overexpression in hypoxia, a hallmark of many solid cancers including TNBC. This study aimed to develop a robust murine TNBC cell line 4T1-based model system that could be used in the comprehensive preclinical evaluation of targeting CAIX. The model is based on the original 4T1 breast cancer cell line and two genetically edited versions of it—one with biallelic CRISPR/Cas9-mediated Car9 inactivation and another with constitutively expressed Car9, thus ensuring negative and positive controls for CAIX production in the model system, respectively. The generated cell lines were validated for CAIX production and characterised functionally in vitro and in vivo after orthotopic implantation in syngeneic BALB/c mice. Results demonstrated signiﬁcantly reduced primary tumour growth and metastatic progression rates in animals with CAIX-deﬁcient tumours, while the CAIX-expressing tumours had vascularised phenotypes with prominent central areas of coagulative necrosis. The differential CAIX expression levels in the model were preserved during tumour growth in syngeneic mice, as veriﬁed by in vivo imaging using a novel high-afﬁnity CAIX-speciﬁc near-infrared (NIR) ﬂuorescent imaging probe, GZ22-4 . Constitutive overexpression of autologous CAIX did not elicit speciﬁc autoantibody responses in vivo, demonstrating the suitability of this model for evaluating the efﬁcacy of anti-CAIX vaccination as a therapeutic strategy. The in vivo study was repeated as an independent experiment and demonstrated good robustness of the developed model.  \nAccording to GLOBOCAN, 2.3 million new breast cancer cases were diagnosed worldwide in 2020, making breast cancer the most frequently diagnosed cancer  \nin both sexes (11.7%) overrunning lung cancer (11 .4%) [1] . Triple-negative breast cancer (TNBC) accounts for about 12–15% of all breast cancers, yet is  \nAbbreviations  \nCA9, carbonic anhydrase 9 gene (human); CAIX, carbonic anhydrase IX; Car9, carbonic anhydrase 9 gene (murine); Cas9, CRISPR-associated protein 9; CMV, cytomegalovirus; CRISPR, clustered regularly interspaced short palindromic repeats; DAPI, 40 ,6-diamidino-2-phenylindole; DMSO, dimethyl sulfoxide; GLOBOCAN, Global Cancer Observatory; H&E, haematoxylin and eosin; IVC, individually ventilated cage; IVIS, in vivo imaging system; mCAIX, murine carbonic anhydrase IX; NIR, near-infrared; pHe, extracellular pH; ROI, region of interest; SPF, speciﬁc pathogen-free; TAA, tumour-associated antigen; TNBC, triple-negative breast cancer.  \nFEBS Open Bio 15 (2025) 1285–1302 ª 2025 The Author(s) . FEBS Open Bio published by John Wiley & Sons Ltd on behalf o","cbCaiowH5OacQDS4","https://ap.wps.com/l/cbCaiowH5OacQDS4","pdf",2830405,18,"English","# Background and Rationale\n# Model System Development\n## Cell Line Engineering and Controls\n# Validation and Characterization\n## In Vitro and In Vivo Assessment\n# Imaging and CAIX Expression Monitoring\n# Immunogenicity and Vaccination Relevance\n# Repeat Study and Robustness","[{\"question\":\"What is the purpose of developing the 4T1-based CAIX model system?\",\"answer\":\"The goal is to create a murine TNBC model suitable for comprehensive preclinical evaluation of targeting CAIX, using genetically edited cell line variants to provide clear negative and positive controls.\"},{\"question\":\"How were the CAIX-modulating cell lines generated and used?\",\"answer\":\"The model is based on the original 4T1 breast cancer line and two edited versions: one with biallelic CRISPR/Cas9-mediated Car9 inactivation and another with constitutive Car9/CAIX expression.\"},{\"question\":\"What did the study show after orthotopic implantation in syngeneic BALB/c mice?\",\"answer\":\"CAIX-deficient tumors exhibited significantly reduced primary tumor growth and metastatic progression, while CAIX-expressing tumors showed vascularized phenotypes with prominent central coagulative necrosis.\"}]","Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies | PDF",1790184311,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa7f86dbc651ef25ca87d610795271c3.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11ba7f41c38e059000d89bbe556b91a3.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/306810605ae94b1d3b62fe7d59464f33.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a6928a3d584beb9f3d34f32065e4fec.webp",980,1287]